Overall Earnings Trend and Market Cap Analysis

The latest quarter saw 428 stocks declare results, with the proportion of companies reporting positive earnings rising to 55.0%, up from 43.0% in September 2025 and 40.0% in June 2025. This upward trajectory suggests improving corporate profitability and operational resilience as the economy navigates post-pandemic recovery phases and global uncertainties.

Breaking down by market capitalisation, mid-cap stocks led the charge with 61.0% delivering positive results, followed by small caps at 56.0%. Large caps lagged behind, with only 38.0% reporting earnings beats. This divergence highlights the relative agility and growth potential of mid and small caps in the current environment, while larger companies face more complex headwinds including global supply chain disruptions and margin pressures.

Sectoral Standouts and Top Performers

Among large caps, Piramal Finance emerged as a top performer, demonstrating robust financial metrics despite the broader challenges faced by the sector. Mid-cap pharmaceutical and biotechnology firm Laurus Labs continued its strong run, benefiting from sustained demand in healthcare and export markets. In the small-cap space, Indo Thai Securities, operating within the capital markets sector, delivered impressive results, reflecting increased market activity and investor participation.

Micro-cap stocks also showcased remarkable performances, with String Metaverse (Paper, Forest & Jute Products) and Sera Investments (Non-Banking Financial Company) topping the charts. These companies exemplify niche sector strength and the potential for outsized returns in less-followed segments of the market.

Chennai Petroleum Corporation Ltd: A Case Study in Earnings Excellence

Among the 19 companies that declared results in the last 24 hours, Chennai Petroleum Corporation Ltd (CPCL) stood out with a very positive financial performance for the December 2025 quarter. The company’s Profit Before Tax excluding Other Income (PBT LESS OI) surged to ₹1,302.39 crores, marking a staggering 244.5% growth compared to its previous four-quarter average. Similarly, Profit After Tax (PAT) rose by 242.5% to ₹1,001.59 crores, both figures representing the highest levels recorded by CPCL in recent quarters.

Net sales for the half-year reached ₹32,010.51 crores, growing by 27.98%, while the Profit Before Depreciation, Interest and Taxes (PBDIT) hit a peak of ₹1,477.95 crores. The operating profit margin also improved significantly, with operating profit to net sales ratio climbing to 9.42%, the highest in recent history. Earnings per share (EPS) for the quarter stood at ₹67.26, underscoring the company’s strong profitability and operational efficiency.

CPCL’s financial score improved from 21 to 25 over the last three months, reflecting a shift from a bullish to a mildly bullish stance as of 16 December 2025. This performance highlights the company’s ability to capitalise on favourable oil market dynamics and operational optimisation.

Sectoral Patterns and Earnings Quality

The pharmaceutical and biotechnology sector, represented by mid-cap Laurus Labs, continues to benefit from robust demand for generic drugs and active pharmaceutical ingredients (APIs), both domestically and internationally. This sector’s resilience is evident in its consistent earnings beats and margin expansion, supported by strong R&D pipelines and export growth.

Conversely, large-cap companies have faced mixed results, with only 38.0% reporting positive earnings surprises. This may be attributed to their exposure to global supply chain constraints, inflationary pressures, and regulatory challenges. However, select large caps like Piramal Finance have bucked the trend, leveraging diversified business models and prudent risk management to deliver solid results.

Small and micro-cap companies have generally outperformed, with 56.0% and notable micro-cap names posting strong earnings growth. These segments benefit from nimble operations, sector-specific tailwinds, and often less market scrutiny, allowing for rapid growth and profitability improvements.

Upcoming Earnings to Watch

Market participants will closely monitor the upcoming results of major companies such as Axis Bank Ltd (due 26 January 2026), Asian Paints Ltd, and CG Power & Industrial Solutions Ltd (both due 27 January 2026). These results will provide further clarity on banking sector health, consumer demand trends, and industrial recovery prospects respectively.

Given the mixed but improving earnings landscape, investors are advised to focus on companies demonstrating consistent earnings quality, margin expansion, and strong cash flow generation. Mid and small caps with sectoral tailwinds remain attractive, while large caps require selective stock picking based on fundamental strength and growth visibility.

Conclusion: Earnings Season Reflects Gradual Recovery with Selective Strength

The December 2025 quarter earnings season paints a picture of gradual recovery and selective strength across the Indian equity market. The rise in positive earnings results to 55.0% signals improving corporate health, particularly among mid and small caps. Sectoral leaders in pharmaceuticals, capital markets, and niche micro-cap segments have delivered standout performances, while large caps face ongoing challenges.

Chennai Petroleum Corporation Ltd’s exceptional quarter exemplifies the potential for strong earnings growth amid favourable market conditions. As the market awaits key results from banking, consumer, and industrial sectors, investors should remain vigilant, favouring companies with demonstrated earnings resilience and growth momentum.

Overall, the earnings season underscores the importance of a nuanced approach to portfolio construction, balancing exposure across market caps and sectors to capitalise on emerging opportunities while managing risks in a complex macroeconomic environment.

Unlock special upgrade rates for a limited period. Start Saving Now →